2型糖尿病、新規血糖降下薬、COVID-19入院、死亡への影響を調べた研究「Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: a nationwide registry analysis」の結果が発表されました。
https://pubmed.ncbi.nlm.nih.gov/35963647/
https://medical-tribune.co.jp/news/2022/0908547086/
2型糖尿病、新規血糖降下薬、COVID-19入院、死亡への影響を調べた研究「Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: a nationwide registry analysis」の結果が発表されました。